ChemoTech is a public listed life science company on Nasdaq First North in Stockholm. We are focusing on the development of innovative cancer treatments.
"We would like to invite cancer researchers internationally to join hands with us in our pursuit of exploring the #TSE technology further" @tech_chemo#pancreaticcancer#electroporation
https://t.co/Dby8goZ7Kb
Scandinavian ChemoTech presents at Redeye Fight Cancer Day Thursday January 19 at 15:25 CET.
Follow digitally via live stream Redeye's event page:
https://t.co/VCA06uqrst
The presentation will be available afterwards on ChemoTechs YouTube channel: https://t.co/GW3j6H8hfT
Scandinavian ChemoTech deltar i en delegation bestående av svenska myndigheter, andra företag och forskningsinstitut i Indien för ett stärkt hälsosamarbete!
@SwecareSweden#india#healthcare#collaboration#acrossborders
https://t.co/qvKOwOyTGb
Scandinavian ChemoTech’s Animal Care division signs significant Clinical Evaluation Agreement with The Royal Veterinary College https://t.co/qqt92estbL
Important update regarding cancer patients treated with IQwave™ Tumour Specific Electroporation™ (TSE) at Ulis Hospital Ukraine https://t.co/SNG6khcI1e
Our Medical Director Mufti Suhail Sayeed is currently travelling and has, amongst other things, visited hospitals in Kenya. Leg two of his journey is with a delegation in Rwanda to foster cooperation in healthcare, arranged by @SwecareSweden .
https://t.co/ZvUxvhTOXl